#AANAM – SEP‑363856 Shows Promise in Easing Parkinson’s Psychosis

#AANAM – SEP‑363856 Shows Promise in Easing Parkinson’s Psychosis

292255

#AANAM – SEP‑363856 Shows Promise in Easing Parkinson’s Psychosis

Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. The investigational medication SEP-363856 might ease symptoms of Parkinson’s disease psychosis, according to data from a small clinical trial. “In this proof-of-concept study, improvements across several scales without worsening motor parkinsonism suggest that SEP-363856 may provide a novel … treatment for [Parkinson’s disease psychosis], particularly for…

You must be logged in to read/download the full post.